Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal PGF Primary Antibody for IHC, ELISA - ABIN1585069
Bagley, Ren, Weber, Yao, Kurtzberg, Pinckney, Bangari, Nguyen, Brondyk, Kaplan, Teicher: Placental growth factor upregulation is a host response to antiangiogenic therapy. in Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Show all 3 references for ABIN1585069
Mouse (Murine) Polyclonal PGF Primary Antibody for IF (p), IHC (p) - ABIN727220
Zhang, Zhao, Yuan, Wu, Jiang, Luo: Placenta growth factor contributes to cell apoptosis and epithelial-to-mesenchymal transition in the hyperoxia-induced acute lung injury. in Life sciences 2016
Show all 2 references for ABIN727220
Human Polyclonal PGF Primary Antibody for ELISA, WB - ABIN4238908
Cao, Ji, Qi, Rosin, Cao: Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. in Biochemical and biophysical research communications 1997
Human Polyclonal PGF Primary Antibody for EIA, WB - ABIN181640
Mohammed, Nasreen, Tepper, Antony: Cyclic stretch induces PlGF expression in bronchial airway epithelial cells via nitric oxide release. in American journal of physiology. Lung cellular and molecular physiology 2007
Human Polyclonal PGF Primary Antibody for ELISA, ICC - ABIN269292
Janér, Andersson, Haglund, Karikoski, Lassus: Placental growth factor and vascular endothelial growth factor receptor-2 in human lung development. in Pediatrics 2008
PlGF is abundant in the human endometrium, and secreted into the uterine lumen where it mediates functional changes in cellular adhesion with important roles in implantation
The preeclampsia group had lower placental growth factor from 18 weeks compared to controls.
A strong, novel prospective association was identified between lower concentrations of soluble Fms (show CSF1R Antibodies)-like kinase 1 and placental growth factor measured in early pregnancy and spontaneous abortion.
Women with preeclampsia had lower plasma concentrations of placental growth factor. The uteroplacental arteriovenous differences of placental growth factor were significant in both preeclampsia and control groups.
Amniotic fluid PlGF levels in the early second trimester of pregnancy are associated with preterm delivery.
PGF concentrations in saliva (show RAG1AP1 Antibodies) and gingival crevicular fluid were no different in patients with pre-eclampsia and controls.
PlGF blood levels are decreased in women who developed early- or late-onset preeclampsia.
The hyperosmotic, but not the hypoxic, PlGF gene expression was in part mediated by NFAT5 (show NFAT5 Antibodies).
Higher plasma VEGF (show VEGFA Antibodies)/PlGF heterodimer levels were found in preterm neonates with BPD (show MOD(MDG4) Antibodies) and in those who died in the first 28 days of life, suggesting an important role of this substance in pulmonary vascular development.
The aim of this study was to investigate whether psoriasis is related to fibroblast growth factor 23 (FGF23 (show FGF23 Antibodies)) and placental growth factor (PLGF) - mediators related to insulin (show INS Antibodies) resistance (IR), metabolic syndrome, and atherosclerosis.
PGF (show PTGFR Antibodies) deficiency is associated with impaired cerebral vascular development in mice.
PlGF inhibition attenuates PERK (show EIF2AK3 Antibodies) activation, likely by tempering hypoxia in HCC (show FAM126A Antibodies) via vessel normalisation. The UPR is able to regulate PlGF expression, suggesting the existence of a feedback mechanism for hypoxia-mediated UPR
Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13 (show IL13 Antibodies).
Data indicate that placental growth factor (PlGF) is needed in the spleen to allow the activation of T cells and blood pressure raising.
Placental growth factor promotes differentiation of bone marrow-derived macrophages and enhanced vascular endothelial cell proliferation.
PLGF in LC cells induced macrophage polarization in vivo, and significantly promoted the growth of LC.
PLGF is upregulated in vascular cells in response to fluid shear stress.
Data suggests that PLGF may target islet endothelia to release growth factors activating PI3k signalling in beta cells to increase their proliferation. In Pre-Eclampsia, PLGF reduction impairs these processes resulting in gestational diabetes mellitus.
The neutrophil elastase (show ELANE Antibodies)-PlGF-JNK (show MAPK8 Antibodies)/PKCdelta (show PKCd Antibodies) pathway contributes to the pathogenesis of lung epithelial cell apoptosis and emphysema.
E2F1 (show E2F1 Antibodies) limits cardiac neovascularization and functional recovery after myocardial infarction by suppressing VEGF (show VEGFA Antibodies) and PlGF up-regulation through p53 (show TP53 Antibodies)-dependent and -independent mechanisms, respectively.
Study reports polymorphisms in the bovine PGF gene significantly associated with the maternal effect (show NLRP5 Antibodies) on stillbirth and calving ease in animals under selection.
placenta growth factor expression is regulated by both VEGF (show VEGFA Antibodies) and hyperglycaemia via VEGFR-2 (show KDR Antibodies)
This gene encodes a growth factor found in placenta which is homologous to vascular endothelial growth factor. Alternatively spliced transcripts encoding different isoforms have been found for this gene.
placental growth factor, vascular endothelial growth factor-related protein
, placenta growth factor
, placenta growth factor-like